| 6001 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T290 | ECGU000290 | 0.31 |
| 6002 | Blood cell traits latent factor 3 (white cell) | GCST90559245 | 0.31 |
| 6003 | PDGFA/USP8 ratio | GCST90315621 | 0.31 |
| 6004 | T1 FreeSurfer DKT lh precentral thickness | GCST90384246 | 0.31 |
| 6005 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T138 | ECGU000138 | 0.31 |
| 6006 | Free cholesterol levels in chylomicrons and extremely large VLDL | GCST90500965 | 0.31 |
| 6007 | Triglyceride levels in VLDL | GCST90093003 | 0.31 |
| 6008 | Pyruvate levels (UKB data field 23472) | GCST90269569 | 0.31 |
| 6009 | Cholesterol in Medium VLDL | GCST90498903 | 0.31 |
| 6010 | Status post-ami | FING00001333 | 0.31 |
| 6011 | Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers) | FING00000877 | 0.31 |
| 6012 | T1 FreeSurfer aseg Left-Pallidum | GCST90384146 | 0.31 |
| 6013 | LAT2 levels | GCST90469739 | 0.31 |
| 6014 | Triglycerides in small VLDL (UKB data field 23515) | GCST90269612 | 0.31 |
| 6015 | LAT/SPARC ratio | GCST90315288 | 0.31 |
| 6016 | Phospholipids in IDL | GCST90497626 | 0.31 |
| 6017 | VSIG2 levels | GCST90471051 | 0.31 |
| 6018 | Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders (more control exclusions) | FING00000101 | 0.31 |
| 6019 | IDP dMRI ProbtrackX ICVF fmi | GCST90004386 | 0.31 |
| 6020 | Left-hemisphere control network to pallidum white-matter structural connectivity | GCST90302755 | 0.31 |
| 6021 | Percentage of fucosylation of monogalactosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP82) | GCST90668526 | 0.31 |
| 6022 | Blood cell traits latent factor 9 (white cell) | GCST90559251 | 0.31 |
| 6023 | VNN1 levels | GCST90471043 | 0.30 |
| 6024 | AXIN1/CALCOCO1 ratio | GCST90313402 | 0.30 |
| 6025 | Left-hemisphere dorsal attention network to putamen white-matter structural connectivity | GCST90302703 | 0.30 |
| 6026 | SCGB1A1 levels | GCST90470540 | 0.30 |
| 6027 | Frequency of drinking alcohol | Alcohol use | UKBB00000260 | 0.30 |
| 6028 | CASP8/SEPTIN9 ratio | GCST90313658 | 0.30 |
| 6029 | Phenylalanine levels | GCST90499223 | 0.30 |
| 6030 | ICD10 N92: Excessive, frequent and irregular menstruation | GCST90454221 | 0.30 |
| 6031 | IDP dMRI TBSS FA Anterior limb of internal capsule R | GCST90003893 | 0.30 |
| 6032 | IKBKG levels | GCST90469542 | 0.30 |
| 6033 | CDSN/NECTIN4 ratio | GCST90313998 | 0.30 |
| 6034 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T366 | ECGA000366 | 0.30 |
| 6035 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 76) | GCST90320639 | 0.30 |
| 6036 | GART levels | GCST90469303 | 0.30 |
| 6037 | SORCS2 levels | GCST90470708 | 0.30 |
| 6038 | Hypertensive chronic kidney disease (PheCode 401.22) | GCST90475927 | 0.30 |
| 6039 | NRAC levels | GCST90617991 | 0.30 |
| 6040 | IDP dMRI TBSS ICVF Cingulum cingulate gyrus R | GCST90004361 | 0.30 |
| 6041 | GFER/MAVS ratio | GCST90314919 | 0.30 |
| 6042 | SUMF1 levels | GCST90470783 | 0.30 |
| 6043 | Total fatty acid levels | GCST90502711 | 0.30 |
| 6044 | ESAM/VSIR ratio | GCST90314721 | 0.30 |
| 6045 | Osteoarthritis (hip) | GCST007091 | 0.30 |
| 6046 | Phospholipids in VLDL | GCST90500266 | 0.30 |
| 6047 | Triglycerides to Total Lipids in Large LDL percentage | GCST90498101 | 0.30 |
| 6048 | IDP dMRI TBSS ICVF Inferior cerebellar peduncle R | GCST90004337 | 0.30 |
| 6049 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T407 | ECGU000407 | 0.30 |
| 6050 | Saturated fatty acids levels | GCST90502674 | 0.30 |
| 6051 | DKK1/VEGFC ratio | GCST90314484 | 0.30 |
| 6052 | Total testosterone levels | GCST90239819 | 0.30 |
| 6053 | Cerotoylcarnitine (C26) levels | GCST90200136 | 0.30 |
| 6054 | Cholesterol levels in medium HDL | GCST90092892 | 0.30 |
| 6055 | ECHS1 levels | GCST90469063 | 0.30 |
| 6056 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T298 | ECGA000298 | 0.30 |
| 6057 | total creatine kinase (maximum, inv-norm transformed) | GCST90476410 | 0.30 |
| 6058 | Other non-toxic goitre | Disorders of thyroid gland | UKBB00000617 | 0.30 |
| 6059 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T193 | ECGU000193 | 0.30 |
| 6060 | Erythematous conditions (PheCode 695) | GCST90476177 | 0.30 |
| 6061 | MMP3 levels | GCST90012027 | 0.30 |
| 6062 | CCL2 levels | GCST90012007 | 0.30 |
| 6063 | Asthma | GCST90086047 | 0.30 |
| 6064 | Triglycerides to Total Lipids in Medium LDL percentage | GCST90498885 | 0.30 |
| 6065 | Major dietary changes in the last 5 years - No | Diet | UKBB00000421 | 0.30 |
| 6066 | Champagne or white wine consumption (glasses per month) (UKB data field 1578, 4418) | GCST90132986 | 0.30 |
| 6067 | CAG-776 abundance in stool | GCST90032297 | 0.30 |
| 6068 | Free cholesterol to total lipids in large LDL percentage (UKB data field 23617) | GCST90269714 | 0.30 |
| 6069 | Alcohol-related disorders | mental disorders | UKBB00000026 | 0.30 |
| 6070 | Sphingomyelin (d18:1/14:0) levels/Sphingomyelin (d16:1/16:0) levels | GCST90024504 | 0.30 |
| 6071 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T399 | ECGU000399 | 0.30 |
| 6072 | GNPDA2 levels | GCST90469374 | 0.29 |
| 6073 | Volume of left lateral nucleus | GCST90474889 | 0.29 |
| 6074 | Microscopic polyangiitis | FING00000817 | 0.29 |
| 6075 | Ever sought or received professional help for mental distress | Mental distress | UKBB00000222 | 0.29 |
| 6076 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T194 | ECGU000194 | 0.29 |
| 6077 | C1S levels | GCST90468494 | 0.29 |
| 6078 | Cholesteryl ester levels in large VLDL | GCST90092870 | 0.29 |
| 6079 | Total fatty acid levels | GCST90502727 | 0.29 |
| 6080 | CNTN3 levels | GCST90468805 | 0.29 |
| 6081 | Acid reflux/GERD | GCST90475320 | 0.29 |
| 6082 | Phosphatidylcholine-2O_32:0_[M+H]1+ levels | GCST90060244 | 0.29 |
| 6083 | CLEC1B/MPIG6B ratio | GCST90314098 | 0.29 |
| 6084 | GAL/PM20D1 ratio | GCST90314917 | 0.29 |
| 6085 | Free Cholesterol to Total Lipids in Very Small VLDL percentage | GCST90500798 | 0.29 |
| 6086 | IDP dMRI TBSS L3 Anterior limb of internal capsule R | GCST90004187 | 0.29 |
| 6087 | SERPINC1 levels | GCST90470594 | 0.29 |
| 6088 | AHNAK levels | GCST90468261 | 0.29 |
| 6089 | LYN levels | GCST90469826 | 0.29 |
| 6090 | Reticulocyte count (UKB data field 30250) | GCST90468100 | 0.29 |
| 6091 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T367 | ECGA000367 | 0.29 |
| 6092 | Concentration of small VLDL particles | GCST90499856 | 0.29 |
| 6093 | DTI TBSS MD Superior corona radiata R | GCST90384596 | 0.29 |
| 6094 | CCL22 levels | GCST90468574 | 0.29 |
| 6095 | GASK1A levels | GCST90469306 | 0.29 |
| 6096 | LGALS1/LGALS8 ratio | GCST90315314 | 0.29 |
| 6097 | AmygNuclei rh volume Paralaminar-nucleus | GCST90002666 | 0.29 |
| 6098 | PAM levels | GCST90470156 | 0.29 |
| 6099 | SMAD3 levels | GCST90470677 | 0.29 |
| 6100 | PRSS22 levels | GCST90470341 | 0.29 |
| 6101 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T247 | ECGA000247 | 0.29 |
| 6102 | CXADR/GGT1 ratio | GCST90314328 | 0.29 |
| 6103 | IMMT levels | GCST90469609 | 0.29 |
| 6104 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T369 | ECGA000369 | 0.29 |
| 6105 | aseg global volume CC-Posterior | GCST90002607 | 0.29 |
| 6106 | CD19 on IgD- CD27- B cell | GCST90001732 | 0.29 |
| 6107 | Concentration of large VLDL particles | GCST90092875 | 0.29 |
| 6108 | SCARF1 levels | GCST90470536 | 0.29 |
| 6109 | CDC37 levels | GCST90468665 | 0.29 |
| 6110 | ASGR2 levels | GCST90468376 | 0.29 |
| 6111 | White bread liking | GCST90094865 | 0.29 |
| 6112 | IDP dMRI TBSS MD Anterior limb of internal capsule R | GCST90004043 | 0.29 |
| 6113 | MAPKAPK2 levels | GCST90469858 | 0.29 |
| 6114 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T414 | ECGU000414 | 0.29 |
| 6115 | Malignant neoplasm of bronchus and lung | Malignant neoplasms of respiratory and intrathoracic organs | UKBB00000425 | 0.29 |
| 6116 | Citrulline levels | GCST90200403 | 0.29 |
| 6117 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T347 | ECGA000347 | 0.29 |
| 6118 | IDP dMRI TBSS L1 Superior longitudinal fasciculus R | GCST90004115 | 0.29 |
| 6119 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T417 | ECGU000417 | 0.29 |
| 6120 | NPHS2 levels | GCST90470071 | 0.29 |
| 6121 | Age-related hearing impairment (MTAG) | GCST90012115 | 0.29 |
| 6122 | NAP1L4 levels | GCST90469998 | 0.29 |
| 6123 | Left-hemisphere somatomotor network to right-hemisphere somatomotor network white-matter structural connectivity | GCST90302676 | 0.29 |
| 6124 | MAP4K5/TBCC ratio | GCST90315385 | 0.29 |
| 6125 | Blood cell traits latent factor 16 (white cell) | GCST90559258 | 0.29 |
| 6126 | IDP dMRI TBSS ICVF Superior corona radiata R | GCST90004351 | 0.29 |
| 6127 | Other chondrocalcinosis | FING00000977 | 0.29 |
| 6128 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T87 | ECGA000087 | 0.29 |
| 6129 | Tiglylcarnitine (C5:1-DC) levels | GCST90199800 | 0.29 |
| 6130 | Concentration of VLDL particles (UKB data field 23428) | GCST90269525 | 0.29 |
| 6131 | APCS levels | GCST90428463 | 0.29 |
| 6132 | AMBP levels | GCST90468288 | 0.29 |
| 6133 | CRELD2/TXNDC5 ratio | GCST90314259 | 0.28 |
| 6134 | CFP levels | GCST90468731 | 0.28 |
| 6135 | NRCAM/PCDH17 ratio | GCST90315553 | 0.28 |
| 6136 | SOST/SPP1 ratio | GCST90315871 | 0.28 |
| 6137 | Biological Father: High cholesterol | GCST90475242 | 0.28 |
| 6138 | F11R/GP1BA ratio | GCST90314722 | 0.28 |
| 6139 | Metabolic syndrome | GCST009602 | 0.28 |
| 6140 | ADH1B levels | GCST90468243 | 0.28 |
| 6141 | Saturated fatty acids to total fatty acids percentage | GCST90502700 | 0.28 |
| 6142 | Cholesteryl esters to total lipids in medium LDL percentage (UKB data field 23621) | GCST90269718 | 0.28 |
| 6143 | CDKN1A/FOXO1 ratio | GCST90313970 | 0.28 |
| 6144 | Omega-6 fatty acids to total fatty acids percentage | GCST90502528 | 0.28 |
| 6145 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T343 | ECGA000343 | 0.28 |
| 6146 | DTI TBSS L2 Anterior limb of internal capsule L | GCST90384493 | 0.28 |
| 6147 | BMP10 levels | GCST90468452 | 0.28 |
| 6148 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 108) | GCST90320927 | 0.28 |
| 6149 | Getting up in morning | Sleep | UKBB00000285 | 0.28 |
| 6150 | Butyrylcarnitine levels | GCST90243589 | 0.28 |
| 6151 | 2-aminobutyrate levels | GCST90243584 | 0.28 |
| 6152 | Cholesteryl esters to total lipids in very small VLDL percentage (UKB data field 23606) | GCST90269703 | 0.28 |
| 6153 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T360 | ECGA000360 | 0.28 |
| 6154 | Operative procedures - Primary total prosthetic replacement of knee joint using cement | Summary Operations | UKBB00000588 | 0.28 |
| 6155 | Monounsaturated fatty acids to total fatty acids percentage | GCST90502051 | 0.28 |
| 6156 | Cutaneous abscess, furuncle and carbuncle | FING00000373 | 0.28 |
| 6157 | Cervical cancer | GCST90011816 | 0.28 |
| 6158 | aparc-DKTatlas lh volume supramarginal | GCST90002891 | 0.28 |
| 6159 | Pain in joint | FING00001137 | 0.28 |
| 6160 | GNE levels | GCST90469370 | 0.28 |
| 6161 | Generalized anxiety disorder | FING00000566 | 0.28 |
| 6162 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T119 | ECGU000119 | 0.28 |
| 6163 | Free cholesterol levels in large VLDL | GCST90092872 | 0.28 |
| 6164 | IDP T1 FAST ROIs L ventral striatum | GCST90002559 | 0.28 |
| 6165 | Liver fat | GCST90566817 | 0.28 |
| 6166 | DDX58 levels | GCST90468977 | 0.28 |
| 6167 | aparc-Desikan rh area precuneus | GCST90003131 | 0.28 |
| 6168 | aparc-a2009s lh area Pole-temporal | GCST90003339 | 0.28 |
| 6169 | Total lipids in small VLDL | GCST90499840 | 0.28 |
| 6170 | Colonic or urogenital fistula | FING00000315 | 0.28 |
| 6171 | IDP dMRI ProbtrackX ISOVF unc l | GCST90004550 | 0.28 |
| 6172 | Foveal thickness | GCST90624113 | 0.28 |
| 6173 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T110 | ECGU000110 | 0.28 |
| 6174 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T167 | ECGA000167 | 0.28 |
| 6175 | Savoury biscuit liking | GCST90094834 | 0.28 |
| 6176 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T192 | ECGU000192 | 0.28 |
| 6177 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T214 | ECGA000214 | 0.28 |
| 6178 | IDP dMRI TBSS L2 Anterior limb of internal capsule R | GCST90004139 | 0.28 |
| 6179 | Cholesterol levels in very large HDL | GCST90093004 | 0.28 |
| 6180 | Operative procedures - Closed reduction of fracture of bone and fixation using nail or screw | Summary Operations | UKBB00000575 | 0.28 |
| 6181 | ERBB4 levels | GCST90469141 | 0.28 |
| 6182 | TNFRSF1A levels | GCST90470910 | 0.28 |
| 6183 | BA-exvivo rh area BA3a | GCST90003223 | 0.28 |
| 6184 | ATP5IF1/F2R ratio | GCST90313384 | 0.28 |
| 6185 | Liver liking | GCST90094794 | 0.28 |
| 6186 | DTI autoptx FA ptr l tract | GCST90385131 | 0.28 |
| 6187 | GFER levels | GCST90469326 | 0.28 |
| 6188 | aparc-DKTatlas rh area precuneus | GCST90003288 | 0.28 |
| 6189 | Frequency of depressed mood in last 2 weeks | Mental health | UKBB00000259 | 0.28 |
| 6190 | Triglycerides to Total Lipids in Large VLDL percentage | GCST90498293 | 0.28 |
| 6191 | mean corpuscular hemoglobin (MCH, minimum, inv-norm transformed) | GCST90475448 | 0.28 |
| 6192 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T450 | ECGA000450 | 0.28 |
| 6193 | Paternal history of Alzheimer's disease | GCST005920 | 0.28 |
| 6194 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T130 | ECGA000130 | 0.28 |
| 6195 | Impacted cerumen (PheCode 380.4) | GCST90475901 | 0.28 |
| 6196 | IDP dMRI TBSS L2 Superior longitudinal fasciculus L | GCST90004164 | 0.28 |
| 6197 | IDP dMRI TBSS L2 Cingulum cingulate gyrus R | GCST90004157 | 0.27 |
| 6198 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T365 | ECGA000365 | 0.27 |
| 6199 | SERPINB13 levels | GCST90423326 | 0.27 |
| 6200 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T405 | ECGU000405 | 0.27 |
| 6201 | GFRA1/TNFRSF1A ratio | GCST90314924 | 0.27 |
| 6202 | AZU1/RNASE3 ratio | GCST90313428 | 0.27 |
| 6203 | PLXNB3/SNAP23 ratio | GCST90315693 | 0.27 |
| 6204 | AmygNuclei lh volume Medial-nucleus | GCST90002653 | 0.27 |
| 6205 | GIT1 levels | GCST90469351 | 0.27 |
| 6206 | MIF levels | GCST90089018 | 0.27 |
| 6207 | ITGB1BP2/LAT2 ratio | GCST90315212 | 0.27 |
| 6208 | EIF4G1/HEXIM1 ratio | GCST90314635 | 0.27 |
| 6209 | Free cholesterol to total lipids in very large VLDL percentage (UKB data field 23587) | GCST90269684 | 0.27 |
| 6210 | Left-hemisphere control network to right-hemisphere visual network white-matter structural connectivity | GCST90302745 | 0.27 |
| 6211 | PMVK/PRTFDC1 ratio | GCST90315695 | 0.27 |
| 6212 | AMBP/HAVCR1 ratio | GCST90313254 | 0.27 |
| 6213 | APOA1 levels | GCST90092808 | 0.27 |
| 6214 | LTA levels | GCST90469813 | 0.27 |
| 6215 | Raynaud's syndrome | GCST90448187 | 0.27 |
| 6216 | BCAM/NOTCH1 ratio | GCST90313474 | 0.27 |
| 6217 | ATP5IF1/HSPA1A ratio | GCST90313388 | 0.27 |
| 6218 | FYB1/MESD ratio | GCST90314911 | 0.27 |
| 6219 | FXN levels | GCST90469282 | 0.27 |
| 6220 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T133 | ECGA000133 | 0.27 |
| 6221 | BAP18 levels | GCST90468422 | 0.27 |
| 6222 | IDP dMRI TBSS ICVF Retrolenticular part of internal capsule L | GCST90004348 | 0.27 |
| 6223 | MENT levels | GCST90469886 | 0.27 |
| 6224 | NPPB levels | GCST90470074 | 0.27 |
| 6225 | BMP6/SPINT2 ratio | GCST90313529 | 0.27 |
| 6226 | Total lipid levels in large VLDL | GCST90092874 | 0.27 |
| 6227 | TGOLN2 levels | GCST90470850 | 0.27 |
| 6228 | Monounsaturated fatty acid levels | GCST90502038 | 0.27 |
| 6229 | Glycoprotein acetyls levels | GCST90092821 | 0.27 |
| 6230 | Abnormality of gait (PheCode 350.2) | GCST90475841 | 0.27 |
| 6231 | CXCL1 levels | GCST90468930 | 0.27 |
| 6232 | DNMBP/PTPN1 ratio | GCST90314517 | 0.27 |
| 6233 | QPCT/RNASET2 ratio | GCST90315758 | 0.27 |
| 6234 | Free Cholesterol to Total Lipids in Small HDL percentage | GCST90499436 | 0.27 |
| 6235 | FXN/TRIAP1 ratio | GCST90314899 | 0.27 |
| 6236 | CCL18/TFPI ratio | GCST90313691 | 0.27 |
| 6237 | Varicose veins | GCST90086144 | 0.27 |
| 6238 | Ceramide (d18:2/24:0) levels | GCST90024055 | 0.27 |
| 6239 | CLEC1B/HEXIM1 ratio | GCST90314093 | 0.27 |
| 6240 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T136 | ECGU000136 | 0.27 |
| 6241 | End-diastolic bi-ventricular shape (principal component 2) | GCST90448481 | 0.27 |
| 6242 | SERPINB1 levels | GCST90470589 | 0.27 |
| 6243 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T199 | ECGU000199 | 0.27 |
| 6244 | IL10RB levels | GCST90469545 | 0.27 |
| 6245 | Non-mucinous epithelial ovarian cancer | GCST90244167 | 0.27 |
| 6246 | CD40/CRELD2 ratio | GCST90313811 | 0.27 |
| 6247 | TMEM106A levels | GCST90470886 | 0.27 |
| 6248 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T136 | ECGA000136 | 0.27 |
| 6249 | Liver iron content | GCST90016674 | 0.27 |
| 6250 | T1 FIRST volume BrStem | GCST90383989 | 0.27 |
| 6251 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T144 | ECGU000144 | 0.27 |
| 6252 | PRKAB1 levels | GCST90470324 | 0.27 |
| 6253 | Lifespan | GCST90551886 | 0.27 |
| 6254 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T293 | ECGU000293 | 0.27 |
| 6255 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T368 | ECGA000368 | 0.27 |
| 6256 | Triglyceride (52:5) levels | GCST90488320 | 0.27 |
| 6257 | Volume of right cortico-amygdaloid transition area | GCST90474911 | 0.27 |
| 6258 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T491 | ECGU000491 | 0.27 |
| 6259 | SNX9 levels | GCST90470703 | 0.27 |
| 6260 | Total concentration of lipoprotein particles (UKB data field 23427) | GCST90269524 | 0.27 |
| 6261 | CD300LG/TNFRSF1A ratio | GCST90313803 | 0.26 |
| 6262 | Smoking/smokers in household | Smoking | UKBB00000783 | 0.26 |
| 6263 | MANF/PRDX5 ratio | GCST90315365 | 0.26 |
| 6264 | PIK3IP1 levels | GCST90470234 | 0.26 |
| 6265 | Atrial fibrillation | GCST90624412 | 0.26 |
| 6266 | Cholesterol in Medium LDL | GCST90498703 | 0.26 |
| 6267 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 72) | GCST90320635 | 0.26 |
| 6268 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T297 | ECGA000297 | 0.26 |
| 6269 | DTI TBSS FA Retrolenticular part of internal capsule R | GCST90384400 | 0.26 |
| 6270 | Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523 | FING00000304 | 0.26 |
| 6271 | Free cholesterol to total lipids ratio in medium HDL | GCST90092897 | 0.26 |
| 6272 | rfMRI amplitudes (ICA100 node 30) | GCST90004618 | 0.26 |
| 6273 | EIF4B/IPCEF1 ratio | GCST90314622 | 0.26 |
| 6274 | TNFSF12 levels | GCST90470919 | 0.26 |
| 6275 | TEK levels | GCST90470829 | 0.26 |
| 6276 | Phospholipids in very large VLDL | GCST90500644 | 0.26 |
| 6277 | aseg lh volume Pallidum | GCST90002623 | 0.26 |
| 6278 | GM2A levels | GCST90469365 | 0.26 |
| 6279 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T435 | ECGU000435 | 0.26 |
| 6280 | Left-hemisphere control network to right-hemisphere dorsal attention network white-matter structural connectivity | GCST90302747 | 0.26 |
| 6281 | EPHB6/TNFRSF9 ratio | GCST90314682 | 0.26 |
| 6282 | Breast cancer | GCST90468117 | 0.26 |
| 6283 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T200 | ECGU000200 | 0.26 |
| 6284 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T455 | ECGU000455 | 0.26 |
| 6285 | Diacylglycerol_36:2_[M+H-H2O]1+ levels | GCST90060191 | 0.26 |
| 6286 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T135 | ECGU000135 | 0.26 |
| 6287 | SERPINB1/TMSB10 ratio | GCST90315830 | 0.26 |
| 6288 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T289 | ECGU000289 | 0.26 |
| 6289 | Plasma 11beta-hydroxyandrosterone glucuronide levels in chronic kidney disease | GCST90264321 | 0.26 |
| 6290 | Cauliflower liking | GCST90094727 | 0.26 |
| 6291 | Vitamin and mineral supplements - None of the above | Medication | UKBB00000901 | 0.26 |
| 6292 | SAMD9L levels | GCST90470524 | 0.26 |
| 6293 | REST UKBBICA NODEamps25 0014 | GCST90385497 | 0.26 |
| 6294 | Lysophosphatidylcholine (26:0) [sn1] levels | GCST90024188 | 0.26 |
| 6295 | TNFRSF19 levels | GCST90470909 | 0.26 |
| 6296 | Left-hemisphere visual network to accumbens white-matter structural connectivity | GCST90302668 | 0.26 |
| 6297 | Triglycerides in very small VLDL | GCST90500885 | 0.26 |
| 6298 | total cholesterol (maximum, inv-norm transformed) | GCST90476420 | 0.26 |
| 6299 | Right ventricular end diastolic volume (MTAG) | GCST90134592 | 0.26 |
| 6300 | Cardiovascular diseases (excluding rheumatic etc) | FING00000255 | 0.26 |
| 6301 | DTI autoptx L3 cgc r tract | GCST90385198 | 0.26 |
| 6302 | Triacylglycerol_56:4_[M+NH4]1+ levels | GCST90060556 | 0.26 |
| 6303 | Spread type: Butter and margarine spreads vs oil-based spreads (UKB data field 1428) | GCST90132951 | 0.26 |
| 6304 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 109) | GCST90320672 | 0.26 |
| 6305 | RSPO1/SFRP1 ratio | GCST90315791 | 0.26 |
| 6306 | RNF41/WWP2 ratio | GCST90315782 | 0.26 |
| 6307 | PLAU/PLAUR ratio | GCST90315674 | 0.26 |
| 6308 | Average diameter for VLDL particles | GCST90093002 | 0.26 |
| 6309 | Right-hemisphere visual network to right-hemisphere dorsal attention network white-matter structural connectivity | GCST90302776 | 0.26 |
| 6310 | CD160/CXCL16 ratio | GCST90313728 | 0.26 |
| 6311 | CD300E/LILRA5 ratio | GCST90313798 | 0.26 |
| 6312 | SNAP23/ZBTB16 ratio | GCST90315858 | 0.26 |
| 6313 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T488 | ECGU000488 | 0.26 |
| 6314 | RUNX3 levels | GCST90242706 | 0.26 |
| 6315 | GGT1/IL1RL2 ratio | GCST90314929 | 0.26 |
| 6316 | Glycoprotein acetyls levels | GCST90497320 | 0.26 |
| 6317 | ELOA levels | GCST90469104 | 0.26 |
| 6318 | DSG2 levels | GCST90427825 | 0.26 |
| 6319 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T390 | ECGU000390 | 0.26 |
| 6320 | CDC37/SNAP29 ratio | GCST90313935 | 0.26 |
| 6321 | CAG-776 sp000438195 abundance in stool | GCST90032296 | 0.26 |
| 6322 | ITGB1/ITGB2 ratio | GCST90315225 | 0.26 |
| 6323 | Retinal venular width | GCST90270400 | 0.26 |
| 6324 | CDSN/WFDC12 ratio | GCST90313999 | 0.26 |
| 6325 | CTSH levels | GCST90088501 | 0.26 |
| 6326 | T1 CAT volume R InsularCortex | GCST90384003 | 0.26 |
| 6327 | Phospholipids to total lipids ratio in small LDL | GCST90092965 | 0.25 |
| 6328 | HDL x anxiety interaction (2df test) | GCST90570665 | 0.25 |
| 6329 | CCL25 levels | GCST90274768 | 0.25 |
| 6330 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T358 | ECGA000358 | 0.25 |
| 6331 | Omega-3 fatty acid levels | GCST90502056 | 0.25 |
| 6332 | PTPN6 levels | GCST90470377 | 0.25 |
| 6333 | CD20 on IgD- CD24- B cell | GCST90001753 | 0.25 |
| 6334 | APOB/APOA1 ratio | GCST90497156 | 0.25 |
| 6335 | ENTPD6 levels | GCST90469122 | 0.25 |
| 6336 | Hernia of abdominal wall, postoperative | FING00000618 | 0.25 |
| 6337 | QC rfMRI cleaned inverse tSNR | GCST90006358 | 0.25 |
| 6338 | Monocyte count | GCST90025950 | 0.25 |
| 6339 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 81) | GCST90320900 | 0.25 |
| 6340 | White blood cell count | GCST90002375 | 0.25 |
| 6341 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T193 | ECGA000193 | 0.25 |
| 6342 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T168 | ECGU000168 | 0.25 |
| 6343 | CRACR2A levels | GCST90468853 | 0.25 |
| 6344 | Phospholipids to total lipids in very small VLDL percentage (UKB data field 23604) | GCST90269701 | 0.25 |
| 6345 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T168 | ECGA000168 | 0.25 |
| 6346 | ANP32B levels | GCST90240176 | 0.25 |
| 6347 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T470 | ECGU000470 | 0.25 |
| 6348 | IDP dMRI TBSS FA Superior cerebellar peduncle R | GCST90003889 | 0.25 |
| 6349 | NBL1/NECTIN4 ratio | GCST90315514 | 0.25 |
| 6350 | BIN1 levels | GCST90090757 | 0.25 |
| 6351 | Insomnia (weighted GWA) | GCST90267287 | 0.25 |
| 6352 | APP/LAMA4 ratio | GCST90313325 | 0.25 |
| 6353 | ENTPD2 levels | GCST90469120 | 0.25 |
| 6354 | Vanillylmandelate (VMA) levels | GCST90200309 | 0.25 |
| 6355 | rfMRI amplitudes (ICA100 node 2) | GCST90004590 | 0.25 |
| 6356 | FUT8 levels | GCST90469281 | 0.25 |
| 6357 | Cholesteryl esters to total lipids in medium HDL percentage (UKB data field 23641) | GCST90269738 | 0.25 |
| 6358 | GBP4 levels | GCST90469313 | 0.25 |
| 6359 | CD58/ROR1 ratio | GCST90313854 | 0.25 |
| 6360 | potassium (mean, inv-norm transformed) | GCST90476307 | 0.25 |
| 6361 | Concentration of small VLDL particles (UKB data field 23509) | GCST90269606 | 0.25 |
| 6362 | Cancer code, self-reported: prostate cancer (UKB data field 20001_1044) | GCST90041905 | 0.25 |
| 6363 | DNMBP levels | GCST90469023 | 0.25 |
| 6364 | Edema (PheCode 782.3) | GCST90476272 | 0.25 |
| 6365 | CXCL6 levels | GCST90468933 | 0.25 |
| 6366 | AK1/NSFL1C ratio | GCST90313224 | 0.25 |
| 6367 | ITGA6 levels | GCST90469636 | 0.25 |
| 6368 | CLEC1B/PLXNA4 ratio | GCST90314100 | 0.25 |
| 6369 | Insomnia complaints | GCST004695 | 0.25 |
| 6370 | Cholesterol in Small HDL | GCST90499358 | 0.25 |
| 6371 | Cardiac dysrhythmias (PheCode 427) | GCST90475963 | 0.25 |
| 6372 | Cholesterol to total lipids ratio in chylomicrons and extremely large VLDL | GCST90093041 | 0.25 |
| 6373 | ADAM23 levels | GCST90468219 | 0.25 |
| 6374 | Cervical cancer | GCST90018597 | 0.25 |
| 6375 | GC levels | GCST90162564 | 0.25 |
| 6376 | LEPR/NRCAM ratio | GCST90315312 | 0.25 |
| 6377 | Duration of moderate activity | Physical activity | UKBB00000197 | 0.25 |
| 6378 | Docosahexaenoic acid levels | GCST90502254 | 0.25 |
| 6379 | DLL1/EFEMP1 ratio | GCST90314494 | 0.25 |
| 6380 | MANSC4 levels | GCST90469848 | 0.25 |
| 6381 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 119) | GCST90320682 | 0.25 |
| 6382 | HippSubfield rh volume Whole-hippocampal-body | GCST90002709 | 0.25 |
| 6383 | Special factor anxiety/tension in mitochondrial haplogroup U | GCST90264127 | 0.25 |
| 6384 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T165 | ECGA000165 | 0.25 |
| 6385 | Monounsaturated fatty acids to total fatty acids percentage | GCST90502372 | 0.25 |
| 6386 | Retinal thickness (functional principal component 5) | GCST90455725 | 0.25 |
| 6387 | IDP dMRI ProbtrackX L2 cgc r | GCST90004278 | 0.25 |
| 6388 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T169 | ECGU000169 | 0.25 |
| 6389 | CD99/PIK3IP1 ratio | GCST90313929 | 0.25 |
| 6390 | Smoking and associated risk behaviours (confirmatory factor analysis Factor 6) | GCST90309341 | 0.25 |
| 6391 | DLL1 levels | GCST90469004 | 0.25 |
| 6392 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T363 | ECGA000363 | 0.25 |
| 6393 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T270 | ECGA000270 | 0.25 |
| 6394 | Treatment speciality of consultant (recoded) - Urology | Summary Administration | UKBB00000838 | 0.25 |
| 6395 | Aspartate aminotransferase (AST, minimum, inv-norm transformed) | GCST90475124 | 0.25 |
| 6396 | RAB10 levels | GCST90470403 | 0.25 |
| 6397 | Congestive heart failure; nonhypertensive (PheCode 428) | GCST90475981 | 0.25 |
| 6398 | Proline levels | GCST90243457 | 0.25 |
| 6399 | Triglycerides to total lipids in IDL percentage (UKB data field 23613) | GCST90269710 | 0.24 |
| 6400 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T246 | ECGA000246 | 0.24 |
| 6401 | HCLS1 levels | GCST90469437 | 0.24 |
| 6402 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T288 | ECGU000288 | 0.24 |
| 6403 | HippSubfield rh volume molecular-layer-HP-head | GCST90002699 | 0.24 |
| 6404 | Leg fat percentage right (UKB data field 23111) | GCST90468175 | 0.24 |
| 6405 | DAB2/ZBTB16 ratio | GCST90314370 | 0.24 |
| 6406 | ICD10 O00: Ectopic pregnancy | GCST90454227 | 0.24 |
| 6407 | Pain type(s) experienced in last month - Knee pain | Pain | UKBB00000629 | 0.24 |
| 6408 | ART3/RGMA ratio | GCST90313362 | 0.24 |
| 6409 | Ectopic pregnancy | GCST90272883 | 0.24 |
| 6410 | aparc-a2009s rh area S-central | GCST90003415 | 0.24 |
| 6411 | Cholesteryl Esters to Total Lipids in Very Small VLDL percentage | GCST90500764 | 0.24 |
| 6412 | Cholesteryl esters in very large HDL (UKB data field 23555) | GCST90269652 | 0.24 |
| 6413 | Left-hemisphere default mode network to accumbens white-matter structural connectivity | GCST90302773 | 0.24 |
| 6414 | Left-hemisphere default mode network to caudate white-matter structural connectivity | GCST90302768 | 0.24 |
| 6415 | Blood cell traits latent factor 4 (red cell) | GCST90559246 | 0.24 |
| 6416 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 14) | GCST90320577 | 0.24 |
| 6417 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T269 | ECGA000269 | 0.24 |
| 6418 | Fresh fruit consumption | GCST90132979 | 0.24 |
| 6419 | Chalazion | FING00000267 | 0.24 |
| 6420 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T201 | ECGU000201 | 0.24 |
| 6421 | Vascular dementia (subcortical) | FING00001420 | 0.24 |
| 6422 | Unspecified acute lower respiratory infection | FING00001398 | 0.24 |
| 6423 | IDP T1 FAST ROIs L precentral gyrus | GCST90002463 | 0.24 |
| 6424 | IDP dMRI ProbtrackX OD fma | GCST90004460 | 0.24 |
| 6425 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T359 | ECGA000359 | 0.24 |
| 6426 | Principal component-derived dietary pattern 43 | GCST90133048 | 0.24 |
| 6427 | FUCA1 levels | GCST90469275 | 0.24 |
| 6428 | CEACAM16 levels | GCST90468689 | 0.24 |
| 6429 | SERPINE1/SMAD1 ratio | GCST90315833 | 0.24 |
| 6430 | C4BPB levels | GCST90468499 | 0.24 |
| 6431 | RPE levels | GCST90470495 | 0.24 |
| 6432 | IDP dMRI TBSS OD Superior fronto-occipital fasciculus R | GCST90004444 | 0.24 |
| 6433 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T98 | ECGA000098 | 0.24 |
| 6434 | IDP dMRI TBSS L1 Posterior corona radiata L | GCST90004102 | 0.24 |
| 6435 | Triglycerides in very large VLDL | GCST90500671 | 0.24 |
| 6436 | Cholesterol to Total Lipids in Small HDL percentage | GCST90499369 | 0.24 |
| 6437 | BACH1 levels | GCST90468415 | 0.24 |
| 6438 | IL1RL2 levels | GCST90469575 | 0.24 |
| 6439 | ICAM5 levels | GCST90241541 | 0.24 |
| 6440 | IGSF21 levels | GCST90469538 | 0.24 |
| 6441 | ICD10 O13: Gestational hypertension | GCST90454232 | 0.24 |
| 6442 | Triglycerides to Total Lipids in Very Small VLDL percentage | GCST90500900 | 0.24 |
| 6443 | Principal component-derived dietary pattern 42 | GCST90133047 | 0.24 |
| 6444 | PDGF-BB levels | GCST90428430 | 0.24 |
| 6445 | Cholesteryl Esters to Total Lipids in Medium LDL percentage | GCST90498747 | 0.24 |
| 6446 | aparc-a2009s rh volume G-parietal-sup | GCST90003025 | 0.24 |
| 6447 | Activities undertaken to treat anxiety | Anxiety | UKBB00000009 | 0.24 |
| 6448 | Phospholipids in HDL | GCST90497430 | 0.24 |
| 6449 | FOXO1/SNAP23 ratio | GCST90314875 | 0.24 |
| 6450 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T165 | ECGU000165 | 0.24 |
| 6451 | Phosphatidylglycerol (34:1) levels | GCST90025061 | 0.24 |
| 6452 | TGFBI levels | GCST90470845 | 0.24 |
| 6453 | Cholesterol to total lipids in medium VLDL percentage (UKB data field 23595) | GCST90269692 | 0.24 |
| 6454 | CLEC1B/GP1BA ratio | GCST90314091 | 0.24 |
| 6455 | Healthspan | GCST007406 | 0.24 |
| 6456 | ADAMTS15/CLMP ratio | GCST90313170 | 0.24 |
| 6457 | F-seafood liking (derived food-liking factor) | GCST90094836 | 0.24 |
| 6458 | Plasma X-25279 levels in chronic kidney disease | GCST90266835 | 0.24 |
| 6459 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T289 | ECGA000289 | 0.24 |
| 6460 | DECR1/METAP1D ratio | GCST90314448 | 0.24 |
| 6461 | Principal component-derived dietary pattern 27 | GCST90133032 | 0.24 |
| 6462 | RND3 levels | GCST90422230 | 0.24 |
| 6463 | Total diffusion tensor imaging along the perivascular space index | GCST90455546 | 0.24 |
| 6464 | IDP SWI T2star right putamen | GCST90003868 | 0.24 |
| 6465 | Main speciality of consultant (recoded) - Trauma and orthopaedics | Summary Administration | UKBB00000420 | 0.24 |
| 6466 | GP1BA levels | GCST90469380 | 0.24 |
| 6467 | ADM levels | GCST90468246 | 0.24 |
| 6468 | Chronic lymphocytic leukemia | GCST90624738 | 0.24 |
| 6469 | ENO1 levels | GCST90469109 | 0.24 |
| 6470 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T469 | ECGU000469 | 0.24 |
| 6471 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T454 | ECGU000454 | 0.24 |
| 6472 | Blood clot / pulmonary embolism / deep vein thrombosis (DVT) | GCST90475209 | 0.24 |
| 6473 | PARP1 levels | GCST90470160 | 0.24 |
| 6474 | Left-hemisphere visual network to right-hemisphere default mode network white-matter structural connectivity | GCST90302661 | 0.24 |
| 6475 | ALPP/LAMP3 ratio | GCST90313249 | 0.24 |
| 6476 | Histidine levels | GCST90092830 | 0.24 |
| 6477 | Percentage of FA2G1 in total neutral plasma glycans (GPn) (GP61) | GCST90668739 | 0.24 |
| 6478 | SCARB2 levels | GCST90470535 | 0.24 |
| 6479 | Menorrhagia | FING00000808 | 0.24 |
| 6480 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T63 | ECGA000063 | 0.24 |
| 6481 | COL1A1/OMD ratio | GCST90314171 | 0.24 |
| 6482 | SNAP29/SPARC ratio | GCST90315860 | 0.24 |
| 6483 | heart rate (HR, maximum, inv-normal transformed) | GCST90476334 | 0.24 |
| 6484 | REST UKBBICA NET100 1212 | GCST90387066 | 0.24 |
| 6485 | Concentration of VLDL particles | GCST90500246 | 0.24 |
| 6486 | PPP1R12A/SKAP2 ratio | GCST90315710 | 0.24 |
| 6487 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502415 | 0.23 |
| 6488 | X-08402 levels | GCST90243538 | 0.23 |
| 6489 | Reticulocyte count | Blood count | UKBB00000752 | 0.23 |
| 6490 | F2R levels | GCST90012010 | 0.23 |
| 6491 | EGFL7 levels | GCST90469083 | 0.23 |
| 6492 | DTNB levels | GCST90469046 | 0.23 |
| 6493 | Plasma 2-aminobutyrate levels in chronic kidney disease | GCST90264339 | 0.23 |
| 6494 | Principal component-derived dietary pattern 16 | GCST90133021 | 0.23 |
| 6495 | Hereditary hemolytic anemias (PheCode 282) | GCST90475779 | 0.23 |
| 6496 | CDH3/TNFRSF21 ratio | GCST90313953 | 0.23 |
| 6497 | DTI autoptx MD str l tract | GCST90385243 | 0.23 |
| 6498 | MITD1 levels | GCST90469910 | 0.23 |
| 6499 | Total lipids in IDL | GCST90497601 | 0.23 |
| 6500 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T152 | ECGU000152 | 0.23 |
| 6501 | FGF23 levels | GCST90012022 | 0.23 |
| 6502 | IDP dMRI ProbtrackX ICVF ml l | GCST90004392 | 0.23 |
| 6503 | EPHA4 levels | GCST90469131 | 0.23 |
| 6504 | Cardiac arrhythmias | FING00000248 | 0.23 |
| 6505 | IDP dMRI TBSS L1 Cingulum hippocampus L | GCST90004112 | 0.23 |
| 6506 | Saturated fatty acids levels | GCST90499950 | 0.23 |
| 6507 | GAL levels | GCST90012062 | 0.23 |
| 6508 | Cholesteryl esters to total lipids in medium VLDL percentage (UKB data field 23596) | GCST90269693 | 0.23 |
| 6509 | BA-exvivo lh volume V1 | GCST90002844 | 0.23 |
| 6510 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T247 | ECGU000247 | 0.23 |
| 6511 | 1-(1-enyl-stearoyl)-GPE (p-18:0) levels | GCST90199910 | 0.23 |
| 6512 | Linoleic acid to total fatty acids percentage (UKB data field 23456) | GCST90269553 | 0.23 |
| 6513 | SEMA7A levels | GCST90470575 | 0.23 |
| 6514 | Free cholesterol to total lipids in small HDL percentage (UKB data field 23647) | GCST90269744 | 0.23 |
| 6515 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T415 | ECGU000415 | 0.23 |
| 6516 | IRAG2 levels | GCST90469626 | 0.23 |
| 6517 | CX3CL1/PODXL2 ratio | GCST90314326 | 0.23 |
| 6518 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T283 | ECGU000283 | 0.23 |
| 6519 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T76 | ECGU000076 | 0.23 |
| 6520 | Triglycerides in LDL | GCST90498469 | 0.23 |
| 6521 | ESM1 levels | GCST90012068 | 0.23 |
| 6522 | Osteoarthritis | GCST90134288 | 0.23 |
| 6523 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T166 | ECGA000166 | 0.23 |
| 6524 | MZB1/TNFRSF13B ratio | GCST90315509 | 0.23 |
| 6525 | Ulcer of lower limb, not elsewhere classified | FING00001385 | 0.23 |
| 6526 | CCL13/CCL8 ratio | GCST90313676 | 0.23 |
| 6527 | Cholesterol in very large HDL (UKB data field 23554) | GCST90269651 | 0.23 |
| 6528 | aseg rh volume Hippocampus | GCST90002641 | 0.23 |
| 6529 | Tooth agenesis EXCLUDE clefts and syndromes | FING00001368 | 0.23 |
| 6530 | ESAM/JAM2 ratio | GCST90314712 | 0.23 |
| 6531 | wg rh intensity-contrast transversetemporal | GCST90003860 | 0.23 |
| 6532 | MANF/TXNDC5 ratio | GCST90315370 | 0.23 |
| 6533 | ICD10 E28.2: Polycystic ovarian syndrome | GCST90454205 | 0.23 |
| 6534 | FLT3/FLT3LG ratio | GCST90314859 | 0.23 |
| 6535 | Colon polyps | GCST90475319 | 0.23 |
| 6536 | TLR4 levels | GCST90470880 | 0.23 |
| 6537 | Polyunsaturated fatty acid levels | GCST90502133 | 0.23 |
| 6538 | LAT/VASH1 ratio | GCST90315289 | 0.23 |
| 6539 | Volume of right central nucleus | GCST90474916 | 0.23 |
| 6540 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T433 | ECGU000433 | 0.23 |
| 6541 | GSTA1/PBLD ratio | GCST90314994 | 0.23 |
| 6542 | F-caffeinated/sweet liking (derived food-liking factor) | GCST90094720 | 0.23 |
| 6543 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T395 | ECGU000395 | 0.23 |
| 6544 | Reticulocyte fraction of red cells | GCST90002406 | 0.23 |
| 6545 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T498 | ECGU000498 | 0.23 |
| 6546 | Cholesteryl esters to total lipids in very large HDL percentage (UKB data field 23631) | GCST90269728 | 0.23 |
| 6547 | Leg fat percentage (left) | Impedance measures | UKBB00000391 | 0.23 |
| 6548 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T409 | ECGU000409 | 0.23 |
| 6549 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T118 | ECGU000118 | 0.23 |
| 6550 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T258 | ECGU000258 | 0.23 |
| 6551 | SMTN levels | GCST90470689 | 0.23 |
| 6552 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T170 | ECGU000170 | 0.23 |
| 6553 | AAGAB levels | GCST90617473 | 0.23 |
| 6554 | aseg global volume CSF | GCST90002603 | 0.23 |
| 6555 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T154 | ECGU000154 | 0.23 |
| 6556 | Cholesteryl ester levels in medium HDL | GCST90092894 | 0.23 |
| 6557 | BCR levels | GCST90468436 | 0.23 |
| 6558 | Lysophosphatidylcholine (24:0) [sn2] levels | GCST90025426 | 0.23 |
| 6559 | Monounsaturated fatty acid levels | GCST90502363 | 0.23 |
| 6560 | aparc-pial rh area supramarginal | GCST90003204 | 0.23 |
| 6561 | COL28A1 levels | GCST90468815 | 0.23 |
| 6562 | CNTN3/FETUB ratio | GCST90314164 | 0.23 |
| 6563 | Ratio of polyunsaturated fatty acids to monounsaturated fatty acids | GCST90092940 | 0.23 |
| 6564 | IDP dMRI TBSS ICVF Superior cerebellar peduncle L | GCST90004340 | 0.23 |
| 6565 | ENO2/TXNDC5 ratio | GCST90314671 | 0.23 |
| 6566 | Fasting blood insulin | GCST005185 | 0.23 |
| 6567 | TNFRSF11B/TNFSF11 ratio | GCST90315930 | 0.23 |
| 6568 | COX5B/FXN ratio | GCST90314199 | 0.23 |
| 6569 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T271 | ECGA000271 | 0.23 |
| 6570 | Treatment/medication code - gliclazide | Medications | UKBB00000846 | 0.23 |
| 6571 | IDP dMRI TBSS L3 Uncinate fasciculus L | GCST90004216 | 0.23 |
| 6572 | IDP T1 FAST ROIs L parahipp gyrus post | GCST90002519 | 0.23 |
| 6573 | TPMT levels | GCST90470945 | 0.23 |
| 6574 | B3GNT7 levels | GCST90468411 | 0.23 |
| 6575 | HDL cholesterol | GCST002223 | 0.23 |
| 6576 | Inpatient record format - UK HES In Patient (2015 format) | Summary Administration | UKBB00000364 | 0.23 |
| 6577 | Urinary albumin excretion | GCST006586 | 0.23 |
| 6578 | SULT1A1 levels | GCST90470781 | 0.23 |
| 6579 | Plasma 1-methylurate levels in chronic kidney disease | GCST90264240 | 0.23 |
| 6580 | APLP1 levels | GCST90468330 | 0.23 |
| 6581 | ANGPT1/PDGFA ratio | GCST90313266 | 0.23 |
| 6582 | CCER2 levels | GCST90468563 | 0.23 |
| 6583 | CST3/TIMP1 ratio | GCST90314300 | 0.22 |
| 6584 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T486 | ECGA000486 | 0.22 |
| 6585 | Left-hemisphere limbic network to putamen white-matter structural connectivity | GCST90302738 | 0.22 |
| 6586 | Polyglandular dysfunction | FING00001186 | 0.22 |
| 6587 | Cholesterol to Total Lipids in Very Small VLDL percentage | GCST90500731 | 0.22 |
| 6588 | AREG levels | GCST90468347 | 0.22 |
| 6589 | CLEC5A levels | GCST90468776 | 0.22 |
| 6590 | Systemic lupus erythematosus | GCST90014238 | 0.22 |
| 6591 | T1 FreeSurfer DK lh superiortemporal thickness | GCST90385651 | 0.22 |
| 6592 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T90 | ECGA000090 | 0.22 |
| 6593 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T243 | ECGA000243 | 0.22 |
| 6594 | SH2B3/SUGT1 ratio | GCST90315840 | 0.22 |
| 6595 | ADAMTS4 levels | GCST90468226 | 0.22 |
| 6596 | ANGPT1 levels | GCST90468300 | 0.22 |
| 6597 | aparc-a2009s rh volume S-parieto-occipital | GCST90003063 | 0.22 |
| 6598 | MMP10 levels | GCST90469915 | 0.22 |
| 6599 | Concentration of small HDL particles | GCST90092951 | 0.22 |
| 6600 | Free cholesterol in small LDL | GCST90499620 | 0.22 |
| 6601 | DTI autoptx MD cgc l tract | GCST90385224 | 0.22 |
| 6602 | Saturated fatty acids levels | GCST90502192 | 0.22 |
| 6603 | Maximum heart rate during fitness test | ECG during exercise | UKBB00000431 | 0.22 |
| 6604 | ITGB7 levels | GCST90469647 | 0.22 |
| 6605 | Subarachnoid haemorrhage | FING00001339 | 0.22 |
| 6606 | CD63 levels | GCST90468642 | 0.22 |
| 6607 | Non-oily fish consumption | GCST90132994 | 0.22 |
| 6608 | Triglycerides to total lipids in large LDL percentage (UKB data field 23618) | GCST90269715 | 0.22 |
| 6609 | Osteoarthritis of the hip or knee | GCST007092 | 0.22 |
| 6610 | BA-exvivo lh area BA45 | GCST90003215 | 0.22 |
| 6611 | Histidine levels (UKB data field 23463) | GCST90269560 | 0.22 |
| 6612 | TRIM40 levels | GCST90470968 | 0.22 |
| 6613 | LEFTY2 levels | GCST90469752 | 0.22 |
| 6614 | CELA3A/CTRC ratio | GCST90314012 | 0.22 |
| 6615 | Other dorsopathies, not elsewhere classified | FING00001041 | 0.22 |
| 6616 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T128 | ECGU000128 | 0.22 |
| 6617 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T139 | ECGA000139 | 0.22 |
| 6618 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T286 | ECGA000286 | 0.22 |
| 6619 | Medication use (antihypertensives) | GCST90018764 | 0.22 |
| 6620 | Omega-3 fatty acids to Omega-6 fatty acids ratio | GCST90502077 | 0.22 |
| 6621 | Sleep apnea | neurological | UKBB00000774 | 0.22 |
| 6622 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T490 | ECGA000490 | 0.22 |
| 6623 | Cholesteryl ester levels in small VLDL | GCST90092970 | 0.22 |
| 6624 | SULT2A1 levels | GCST90470782 | 0.22 |
| 6625 | DAG1/PDGFB ratio | GCST90314379 | 0.22 |
| 6626 | Total Lipids in HDL | GCST90497401 | 0.22 |
| 6627 | TNFRSF11B levels | GCST90012002 | 0.22 |
| 6628 | Neutrophil percentage of white cells variance | GCST90565701 | 0.22 |
| 6629 | Selective deficiency of immunoglobulin G [IgG] subclasses | FING00001288 | 0.22 |
| 6630 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T121 | ECGA000121 | 0.22 |
| 6631 | ADM levels | GCST90011996 | 0.22 |
| 6632 | JAM2/TNFRSF14 ratio | GCST90315240 | 0.22 |
| 6633 | ENG/NOTCH1 ratio | GCST90314648 | 0.22 |
| 6634 | ESM1 levels | GCST90469153 | 0.22 |
| 6635 | Arthrosis | FING00000111 | 0.22 |
| 6636 | IDP dMRI TBSS ICVF Splenium of corpus callosum | GCST90004331 | 0.22 |
| 6637 | HAVCR2/TREM2 ratio | GCST90315031 | 0.22 |
| 6638 | RELT/TNFRSF1A ratio | GCST90315767 | 0.22 |
| 6639 | CLEC1B/SORT1 ratio | GCST90314104 | 0.22 |
| 6640 | Cholesteryl esters to total lipids ratio in very small VLDL | GCST90093031 | 0.22 |
| 6641 | Panic attacks | Mental distress | UKBB00000634 | 0.22 |
| 6642 | MME levels | GCST90469914 | 0.22 |
| 6643 | Alcohol frequency weekly (standard GWA) | GCST90267266 | 0.22 |
| 6644 | Other diseases of blood and blood-forming organs | FING00000998 | 0.22 |
| 6645 | FABP2/LGALS4 ratio | GCST90314756 | 0.22 |
| 6646 | F2R/SNX9 ratio | GCST90314736 | 0.22 |
| 6647 | Other diseases of the respiratory system | FING00001011 | 0.22 |
| 6648 | CNPY4/ERBIN ratio | GCST90314148 | 0.22 |
| 6649 | DTI TBSS FA Corticospinal tract R | GCST90384386 | 0.22 |
| 6650 | DTI TBSS L3 Posterior thalamic radiation R | GCST90384552 | 0.22 |
| 6651 | Coffee consumption (cups per day) | GCST90132984 | 0.22 |
| 6652 | Right subiculum volume (body) | GCST90267980 | 0.22 |
| 6653 | TRIM25 levels | GCST90470966 | 0.22 |
| 6654 | FCER1A levels | GCST90469198 | 0.22 |
| 6655 | Suppurative and unspecified otitis media | FING00001346 | 0.22 |
| 6656 | IDP dMRI TBSS L1 Genu of corpus callosum | GCST90004077 | 0.22 |
| 6657 | DNMBP/TJAP1 ratio | GCST90314521 | 0.22 |
| 6658 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 92) | GCST90320655 | 0.22 |
| 6659 | LRCH4 levels | GCST90469791 | 0.22 |
| 6660 | TIRAP levels | GCST90243032 | 0.22 |
| 6661 | FGFBP3 levels | GCST90469232 | 0.22 |
| 6662 | BA-exvivo rh thickness V2 | GCST90003537 | 0.22 |
| 6663 | IDP dMRI TBSS L1 Inferior cerebellar peduncle L | GCST90004086 | 0.22 |
| 6664 | Height decline (difference score) | GCST90565863 | 0.21 |
| 6665 | Migraine without aura and triptan purchases | FING00000822 | 0.21 |
| 6666 | Felt very upset when reminded of stressful experience in past month | Traumatic events | UKBB00000243 | 0.21 |
| 6667 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T285 | ECGU000285 | 0.21 |
| 6668 | Cholesterol to total lipids ratio in very large VLDL | GCST90093017 | 0.21 |
| 6669 | Benign paroxysmal vertigo | FING00000210 | 0.21 |
| 6670 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T88 | ECGA000088 | 0.21 |
| 6671 | IDP dMRI ProbtrackX ICVF fma | GCST90004385 | 0.21 |
| 6672 | CANT1/GSTA1 ratio | GCST90313616 | 0.21 |
| 6673 | Phosphatidylcholine_33:4_[M+H]1+/Phosphatidylethanolamine_36:4_[M+H]1+/Phosphatidate_38:5_[M+NH4]1+ levels | GCST90060273 | 0.21 |
| 6674 | Cholesteryl esters in small VLDL (UKB data field 23513) | GCST90269610 | 0.21 |
| 6675 | Other arrhythmias | FING00000962 | 0.21 |
| 6676 | Docosahexaenoic acid to total fatty acids percentage | GCST90502284 | 0.21 |
| 6677 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T140 | ECGA000140 | 0.21 |
| 6678 | Glutamine levels | GCST90497285 | 0.21 |
| 6679 | Percent liver fat | GCST90016673 | 0.21 |
| 6680 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T231 | ECGU000231 | 0.21 |
| 6681 | Hearing (confirmatory factor analysis Factor 32) | GCST90309366 | 0.21 |
| 6682 | Concentration of medium LDL particles | GCST90498819 | 0.21 |
| 6683 | PDCD1/TNFRSF9 ratio | GCST90315611 | 0.21 |
| 6684 | CCL5/TFPI ratio | GCST90313708 | 0.21 |
| 6685 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T142 | ECGU000142 | 0.21 |
| 6686 | IDP dMRI TBSS L1 Splenium of corpus callosum | GCST90004079 | 0.21 |
| 6687 | aseg rh intensity Putamen | GCST90003784 | 0.21 |
| 6688 | ThalamNuclei lh volume PuI | GCST90002714 | 0.21 |
| 6689 | FCGR2A levels | GCST90469200 | 0.21 |
| 6690 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T400 | ECGU000400 | 0.21 |
| 6691 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T198 | ECGU000198 | 0.21 |
| 6692 | Snoring | GCST009762 | 0.21 |
| 6693 | AMOTL2 levels | GCST90468294 | 0.21 |
| 6694 | TAFA5 levels | GCST90470800 | 0.21 |
| 6695 | ENO2 levels | GCST90469110 | 0.21 |
| 6696 | HNMT/SETMAR ratio | GCST90315069 | 0.21 |
| 6697 | X-12749 levels | GCST90243770 | 0.21 |
| 6698 | PLAUR levels | GCST90470251 | 0.21 |
| 6699 | IGFBPL1 levels | GCST90469533 | 0.21 |
| 6700 | CEP20 levels | GCST90468712 | 0.21 |
| 6701 | CDA levels | GCST90468660 | 0.21 |
| 6702 | GM3 ganglioside (d18:1/24:0) levels | GCST90024729 | 0.21 |
| 6703 | Cholesteryl Esters in Large LDL | GCST90497949 | 0.21 |
| 6704 | OPLAH levels | GCST90470127 | 0.21 |
| 6705 | Other and unspecified rosacea | FING00000951 | 0.21 |
| 6706 | Dyslipidemia | GCST90086077 | 0.21 |
| 6707 | Hearing difficulty | GCST90044775 | 0.21 |
| 6708 | Cholesterol to total lipids in large VLDL percentage (UKB data field 23590) | GCST90269687 | 0.21 |
| 6709 | Liver volume | GCST90016666 | 0.21 |
| 6710 | BTD levels | GCST90468477 | 0.21 |
| 6711 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T497 | ECGU000497 | 0.21 |
| 6712 | IDP dMRI ProbtrackX ISOVF ifo l | GCST90004537 | 0.21 |
| 6713 | IRF3 levels | GCST90618743 | 0.21 |
| 6714 | Social trust (aggregated) | GCST90319315 | 0.21 |
| 6715 | Atrial fibrillation and flutter (PheCode 427.2) | GCST90475967 | 0.21 |
| 6716 | Polyunsaturated fatty acid levels | GCST90502142 | 0.21 |
| 6717 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T101 | ECGU000101 | 0.21 |
| 6718 | Cholesteryl Esters to Total Lipids in Small LDL percentage | GCST90499595 | 0.21 |
| 6719 | Left-hemisphere salience/ventral attention network to pallidum white-matter structural connectivity | GCST90302722 | 0.21 |
| 6720 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T164 | ECGU000164 | 0.21 |
| 6721 | Free Cholesterol to Total Lipids in Medium LDL percentage | GCST90498784 | 0.21 |
| 6722 | IDP dMRI TBSS FA Uncinate fasciculus R | GCST90003921 | 0.21 |
| 6723 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T83 | ECGU000083 | 0.21 |
| 6724 | Plasma 16a-hydroxy DHEA 3-sulfate levels in chronic kidney disease | GCST90264328 | 0.21 |
| 6725 | ThalamNuclei lh volume VAmc | GCST90002723 | 0.21 |
| 6726 | KIAA2013 levels | GCST90469679 | 0.21 |
| 6727 | Myeloid white cell count | GCST004626 | 0.21 |
| 6728 | Smoked fish liking | GCST90094841 | 0.21 |
| 6729 | Phosphatidylcholines levels (UKB data field 23437) | GCST90269534 | 0.21 |
| 6730 | EDAR/ITGB1BP2 ratio | GCST90314580 | 0.21 |
| 6731 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T160 | ECGU000160 | 0.21 |
| 6732 | Qualifications - CSEs or equivalent | Education | UKBB00000728 | 0.21 |
| 6733 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T364 | ECGA000364 | 0.21 |
| 6734 | Phospholipids to Total Lipids in IDL percentage | GCST90497644 | 0.21 |
| 6735 | Percentage of monosialylation of core-fucosylated monogalactosylated structures without bisecting GlcNAc (GP41) | GCST90668485 | 0.20 |
| 6736 | CCL18/RARRES2 ratio | GCST90313690 | 0.20 |
| 6737 | Dysmenorrheic pain severity | GCST006656 | 0.20 |
| 6738 | CD163/MARCO ratio | GCST90313737 | 0.20 |
| 6739 | Triglyceride levels in large VLDL | GCST90092878 | 0.20 |
| 6740 | aparc-DKTatlas lh volume pericalcarine | GCST90002881 | 0.20 |
| 6741 | DNAJB14 levels | GCST90427235 | 0.20 |
| 6742 | MMP8 levels | GCST90469922 | 0.20 |
| 6743 | PPM1B levels | GCST90470296 | 0.20 |
| 6744 | Other arthrosis | FING00000965 | 0.20 |
| 6745 | FABP1/RBP2 ratio | GCST90314753 | 0.20 |
| 6746 | Dermatitis due to ingested food | FING00000403 | 0.20 |
| 6747 | Spread type - Other type of spread/margarine | Diet | UKBB00000795 | 0.20 |
| 6748 | XPNPEP2 levels | GCST90471084 | 0.20 |
| 6749 | Platelet count at delivery | GCST90302227 | 0.20 |
| 6750 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T451 | ECGA000451 | 0.20 |
| 6751 | Non-cancer illness code, self-reported - depression | Medical conditions | UKBB00000507 | 0.20 |
| 6752 | Phospholipids to total lipids in medium HDL percentage (UKB data field 23639) | GCST90269736 | 0.20 |
| 6753 | CA5A/GRPEL1 ratio | GCST90313590 | 0.20 |
| 6754 | NFATC1 levels | GCST90470033 | 0.20 |
| 6755 | IPCEF1/TBCB ratio | GCST90315187 | 0.20 |
| 6756 | Valine levels | GCST90500177 | 0.20 |
| 6757 | Cholesterol in Small HDL | GCST90499348 | 0.20 |
| 6758 | CPM/PCSK9 ratio | GCST90314216 | 0.20 |
| 6759 | SPRR3 levels | GCST90470737 | 0.20 |
| 6760 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T468 | ECGU000468 | 0.20 |
| 6761 | MFGE8 levels | GCST90469900 | 0.20 |
| 6762 | DOK2/PPP1R12A ratio | GCST90314536 | 0.20 |
| 6763 | BIN2/FYB1 ratio | GCST90313505 | 0.20 |
| 6764 | GFRA2 levels | GCST90469329 | 0.20 |
| 6765 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T416 | ECGU000416 | 0.20 |
| 6766 | Concentration of medium HDL particles | GCST90092899 | 0.20 |
| 6767 | GFER/TRIAP1 ratio | GCST90314921 | 0.20 |
| 6768 | Carnitine levels | GCST90239991 | 0.20 |
| 6769 | Total lipid levels in VLDL | GCST90092999 | 0.20 |
| 6770 | wg lh intensity-contrast rostralmiddlefrontal | GCST90003818 | 0.20 |
| 6771 | aparc-a2009s rh area S-intrapariet+P-trans | GCST90003426 | 0.20 |
| 6772 | KAZALD1 levels | GCST90469665 | 0.20 |
| 6773 | PEAR1 levels | GCST90470204 | 0.20 |
| 6774 | Radiotherapy (PheCode 196) | GCST90475605 | 0.20 |
| 6775 | Omega-3 fatty acids to total fatty acids percentage | GCST90502467 | 0.20 |
| 6776 | IDP dMRI TBSS MO Posterior corona radiata R | GCST90003978 | 0.20 |
| 6777 | Phospholipids in LDL | GCST90498439 | 0.20 |
| 6778 | IDP T1 SIENAX CSF normalised volume | GCST90002428 | 0.20 |
| 6779 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T60 | ECGU000060 | 0.20 |
| 6780 | Right ventricular ejection fraction | GCST90268117 | 0.20 |
| 6781 | Benign neoplasm of eye, uveal (PheCode 224.1) | GCST90475629 | 0.20 |
| 6782 | DBNL/DNAJA2 ratio | GCST90314415 | 0.20 |
| 6783 | ACY1 levels | GCST90468212 | 0.20 |
| 6784 | Clinical LDL cholesterol levels | GCST90497223 | 0.20 |
| 6785 | Anal and rectal conditions | digestive | UKBB00000029 | 0.20 |
| 6786 | wg rh intensity-contrast bankssts | GCST90003828 | 0.20 |
| 6787 | KIAA0319 levels | GCST90469676 | 0.20 |
| 6788 | Chronic diseases of tonsils and adenoids | FING00000283 | 0.20 |
| 6789 | GRAP2/PLPBP ratio | GCST90314984 | 0.20 |
| 6790 | TFRC levels | GCST90451684 | 0.20 |
| 6791 | Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8 (more control exclusions) | FING00000694 | 0.20 |
| 6792 | Total body bone mineral density (age 0-15) | GCST005345 | 0.20 |
| 6793 | Concentration of small HDL particles | GCST90499461 | 0.20 |
| 6794 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T489 | ECGA000489 | 0.20 |
| 6795 | PALM3 levels | GCST90470153 | 0.20 |
| 6796 | Free Cholesterol in LDL | GCST90498388 | 0.20 |
| 6797 | Total lipids in small VLDL (UKB data field 23510) | GCST90269607 | 0.20 |
| 6798 | NCF2 levels | GCST90470006 | 0.20 |
| 6799 | RNF43 levels | GCST90470486 | 0.20 |
| 6800 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T284 | ECGU000284 | 0.20 |
| 6801 | Androstenediol (3beta,17beta) disulfate (1) levels | GCST90199842 | 0.20 |
| 6802 | BA-exvivo lh area BA4p | GCST90003212 | 0.20 |
| 6803 | Free cholesterol to total lipids ratio in large HDL | GCST90092849 | 0.20 |
| 6804 | Neutrophill count (UKB data field 30140) | GCST90468092 | 0.20 |
| 6805 | Free Cholesterol in VLDL | GCST90500221 | 0.20 |
| 6806 | Disorders of vestibular function (Vertigo) | FING00000464 | 0.20 |
| 6807 | Plasma methylsuccinate levels in chronic kidney disease | GCST90265506 | 0.20 |
| 6808 | Phospholipids to Total Lipids in Small LDL percentage | GCST90499690 | 0.20 |
| 6809 | Bell's palsy | FING00000144 | 0.20 |
| 6810 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T183 | ECGA000183 | 0.20 |
| 6811 | Urine 3-hydroxyindolin-2-one sulfate levels in chronic kidney disease | GCST90264508 | 0.20 |
| 6812 | Depression/anxiety (standard GWA) | GCST90267276 | 0.20 |
| 6813 | CASP2 levels | GCST90468544 | 0.20 |
| 6814 | CHMP1A levels | GCST90468746 | 0.20 |
| 6815 | DAG1/PDGFA ratio | GCST90314378 | 0.20 |
| 6816 | Free cholesterol to total lipids in small LDL percentage (UKB data field 23627) | GCST90269724 | 0.20 |
| 6817 | APP/PPP1R12A ratio | GCST90313330 | 0.20 |
| 6818 | CD300C levels | GCST90468620 | 0.20 |
| 6819 | Parental longevity (father's age at death) | GCST006700 | 0.20 |
| 6820 | Gonarthrosis, primary, with knee surgery | FING00000586 | 0.20 |
| 6821 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T167 | ECGU000167 | 0.20 |
| 6822 | Otitis externa | FING00001128 | 0.20 |
| 6823 | Systolic blood pressure, manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000811 | 0.20 |
| 6824 | CST3/RETN ratio | GCST90314297 | 0.20 |
| 6825 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T130 | ECGU000130 | 0.20 |
| 6826 | Alanine levels | GCST90243582 | 0.20 |
| 6827 | Triacylglycerol_52:2_[M+NH4]1+ levels | GCST90060511 | 0.20 |
| 6828 | Octadecanedioylcarnitine (C18-DC) levels | GCST90199992 | 0.20 |
| 6829 | Intelligence | GCST004364 | 0.20 |
| 6830 | BCAM/EPO ratio | GCST90313471 | 0.20 |
| 6831 | MAD1L1/POLR2F ratio | GCST90315354 | 0.20 |
| 6832 | Cleft hard palate NOS | FING00000306 | 0.20 |
| 6833 | CST3/TAFA5 ratio | GCST90314298 | 0.19 |
| 6834 | Prescriptions - orlistat | lipase inhibitor,obesity | UKBB00000695 | 0.19 |
| 6835 | Prescriptions - lipase inhibitor|obesity | UKBB00000688 | 0.19 |
| 6836 | Asthma and allergy | FING00000115 | 0.19 |
| 6837 | HTRA2/SIAE ratio | GCST90315097 | 0.19 |
| 6838 | FBP1/GSTA1 ratio | GCST90314786 | 0.19 |
| 6839 | EBAG9/TGFB1 ratio | GCST90314570 | 0.19 |
| 6840 | aparc-a2009s rh area S-oc-temp-med+Lingual | GCST90003431 | 0.19 |
| 6841 | Phospholipids to total lipids ratio in IDL | GCST90092840 | 0.19 |
| 6842 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T169 | ECGA000169 | 0.19 |
| 6843 | BTN2A1/IL18BP ratio | GCST90313545 | 0.19 |
| 6844 | THBD levels | GCST90012048 | 0.19 |
| 6845 | NPPC levels | GCST90470075 | 0.19 |
| 6846 | IDP dMRI TBSS MD Posterior limb of internal capsule L | GCST90004046 | 0.19 |
| 6847 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T88 | ECGU000088 | 0.19 |
| 6848 | Cholesteryl Esters in HDL | GCST90497357 | 0.19 |
| 6849 | Hyperparathyroidism (PheCode 252.1) | GCST90475693 | 0.19 |
| 6850 | AMBN levels | GCST90468287 | 0.19 |
| 6851 | Ulcerative rectosigmoiditis | FING00001394 | 0.19 |
| 6852 | Neuroticism score | Mental health | UKBB00000496 | 0.19 |
| 6853 | KLK10 levels | GCST90469696 | 0.19 |
| 6854 | CLEC4A levels | GCST90468771 | 0.19 |
| 6855 | TPK1 levels | GCST90470943 | 0.19 |
| 6856 | SEMA3F levels | GCST90470570 | 0.19 |
| 6857 | LY6D levels | GCST90469821 | 0.19 |
| 6858 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T117 | ECGU000117 | 0.19 |
| 6859 | Pregnancy hypertension | FING00001204 | 0.19 |
| 6860 | Cholesteryl ester levels in chylomicrons and extremely large VLDL | GCST90500943 | 0.19 |
| 6861 | IDP dMRI TBSS ICVF Tapetum R | GCST90004373 | 0.19 |
| 6862 | Exposure to tobacco smoke at home | Smoking | UKBB00000228 | 0.19 |
| 6863 | Cognition and processing speed (confirmatory factor analysis Factor 34) | GCST90309368 | 0.19 |
| 6864 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T288 | ECGA000288 | 0.19 |
| 6865 | Left ventricular end diastole inferolateral wall thickness | GCST90278516 | 0.19 |
| 6866 | Sphingomyelin (d16:1/23:0) levels/Sphingomyelin (d17:1/22:0) levels | GCST90025735 | 0.19 |
| 6867 | CASP3/SERPINB9 ratio | GCST90313642 | 0.19 |
| 6868 | aparc-Desikan lh volume pericalcarine | GCST90002788 | 0.19 |
| 6869 | IMPA1 levels | GCST90469610 | 0.19 |
| 6870 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T155 | ECGU000155 | 0.19 |
| 6871 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T141 | ECGU000141 | 0.19 |
| 6872 | Metabolic disorders | FING00000816 | 0.19 |
| 6873 | aseg rh volume Pallidum | GCST90002640 | 0.19 |
| 6874 | Phospholipids in large LDL | GCST90498049 | 0.19 |
| 6875 | PCDH17/THBD ratio | GCST90315607 | 0.19 |
| 6876 | aparc-Desikan rh volume pericalcarine | GCST90002821 | 0.19 |
| 6877 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T257 | ECGU000257 | 0.19 |
| 6878 | DTI TBSS L3 External capsule L | GCST90384557 | 0.19 |
| 6879 | FKBP5 levels | GCST90469244 | 0.19 |
| 6880 | Adhesive capsulitis of shoulder | FING00000043 | 0.19 |
| 6881 | Gout, strict definition | FING00000588 | 0.19 |
| 6882 | Postmenopausal breast cancer | GCST90428116 | 0.19 |
| 6883 | Total cholesterol levels in medium VLDL | GCST90132689 | 0.19 |
| 6884 | FCRL3 levels | GCST90469207 | 0.19 |
| 6885 | Prescriptions - doxazosin | alpha1-antagonist,alpha blocker | UKBB00000679 | 0.19 |
| 6886 | Triglycerides to total lipids ratio in very large HDL | GCST90093015 | 0.19 |
| 6887 | Glomerular diseases | FING00000581 | 0.19 |
| 6888 | Lysophosphatidylcholine (26:0) [sn1] levels | GCST90025427 | 0.19 |
| 6889 | aseg rh volume Lateral-Ventricle | GCST90002633 | 0.19 |
| 6890 | aseg lh intensity Putamen | GCST90003770 | 0.19 |
| 6891 | MMP12 levels | GCST90012070 | 0.19 |
| 6892 | 3-Hydroxybutyrate levels | GCST90092811 | 0.19 |
| 6893 | Cholesteryl esters to total lipids ratio in large VLDL | GCST90092871 | 0.19 |
| 6894 | Left-hemisphere visual network to left-hemisphere visual network white-matter structural connectivity | GCST90302648 | 0.19 |
| 6895 | CD83/HAVCR2 ratio | GCST90313904 | 0.19 |
| 6896 | Free cholesterol to total lipids ratio in very large VLDL | GCST90093021 | 0.19 |
| 6897 | SPESP1 levels | GCST90470720 | 0.19 |
| 6898 | Free Cholesterol to Total Lipids in Medium HDL percentage | GCST90498583 | 0.19 |
| 6899 | SEPTIN8 levels | GCST90470578 | 0.19 |
| 6900 | Other embolism and thrombosis | FING00001043 | 0.19 |
| 6901 | Platelet count during second trimester of pregnancy | GCST90302225 | 0.19 |
| 6902 | Type 1 diabetes | GCST90018705 | 0.19 |
| 6903 | Cholesterol to total lipids in IDL percentage (UKB data field 23610) | GCST90269707 | 0.19 |
| 6904 | Dimethylglycine levels | GCST90200424 | 0.19 |
| 6905 | Sphingomyelins levels (UKB data field 23438) | GCST90269535 | 0.19 |
| 6906 | AGR2 levels | GCST90468253 | 0.19 |
| 6907 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 92) | GCST90320911 | 0.19 |
| 6908 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T453 | ECGU000453 | 0.19 |
| 6909 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90502555 | 0.19 |
| 6910 | Phospholipids in medium LDL | GCST90498832 | 0.19 |
| 6911 | Average diameter for VLDL particles | GCST90500290 | 0.19 |
| 6912 | HAVCR2 levels | GCST90421515 | 0.19 |
| 6913 | IDP dMRI ProbtrackX L2 cgc l | GCST90004277 | 0.19 |
| 6914 | Endometriosis of pelvic peritoneum | FING00000502 | 0.19 |
| 6915 | Cholesteryl Esters to Total Lipids in Small VLDL percentage | GCST90499800 | 0.19 |
| 6916 | Arterial embolism and thrombosis of lower extremity artery | FING00000106 | 0.19 |
| 6917 | IDP dMRI ProbtrackX L1 atr r | GCST90004249 | 0.19 |
| 6918 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T268 | ECGA000268 | 0.19 |
| 6919 | C1QA levels | GCST90468485 | 0.19 |
| 6920 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T215 | ECGA000215 | 0.19 |
| 6921 | TREML2 levels | GCST90470962 | 0.19 |
| 6922 | Pilonidal cyst | FING00001167 | 0.18 |
| 6923 | Coffee type: Instant coffee (UKB data field 1508_2) | GCST90041802 | 0.18 |
| 6924 | Cylindrical power (right) | Autorefraction | UKBB00000162 | 0.18 |
| 6925 | Total Phosphatidylcholine levels | GCST90025204 | 0.18 |
| 6926 | Polyunsaturated fatty acid levels | GCST90502622 | 0.18 |
| 6927 | Heart failure | GCST90399712 | 0.18 |
| 6928 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T224 | ECGA000224 | 0.18 |
| 6929 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T158 | ECGU000158 | 0.18 |
| 6930 | BA-exvivo rh area BA3b | GCST90003224 | 0.18 |
| 6931 | CANT1 levels | GCST90468536 | 0.18 |
| 6932 | IDP T1 SIENAX CSF unnormalised volume | GCST90002429 | 0.18 |
| 6933 | Linoleic acid levels | GCST90498306 | 0.18 |
| 6934 | Concentration of medium HDL particles | GCST90498617 | 0.18 |
| 6935 | Job involves heavy manual or physical work | Employment | UKBB00000383 | 0.18 |
| 6936 | ACE2/GGT1 ratio | GCST90313153 | 0.18 |
| 6937 | SARG levels | GCST90470526 | 0.18 |
| 6938 | Open wounds of extremities (PheCode 871) | GCST90476285 | 0.18 |
| 6939 | IDP T1 FIRST left caudate volume | GCST90002438 | 0.18 |
| 6940 | Atrial fibrillation (PheCode 427.21) | GCST90475970 | 0.18 |
| 6941 | wg lh intensity-contrast pericalcarine | GCST90003812 | 0.18 |
| 6942 | Brainstem global volume Pons | GCST90002765 | 0.18 |
| 6943 | ADGRF5 levels | GCST90468239 | 0.18 |
| 6944 | CCS levels | GCST90468594 | 0.18 |
| 6945 | CETN2/TDRKH ratio | GCST90314031 | 0.18 |
| 6946 | Methionine sulfone levels | GCST90199961 | 0.18 |
| 6947 | EREG/ITGB1BP2 ratio | GCST90314703 | 0.18 |
| 6948 | F2R/SERPINE1 ratio | GCST90314735 | 0.18 |
| 6949 | Free cholesterol in small LDL | GCST90499617 | 0.18 |
| 6950 | 1-methylhistidine metabolite level | GCST90615480 | 0.18 |
| 6951 | Gut bacterial pathway abundance (PYRIDNUCSYN.PWY..NAD.biosynthesis.I..from.aspartate.) | GCST90027638 | 0.18 |
| 6952 | PROK2 levels | GCST90617073 | 0.18 |
| 6953 | 1-stearoyl-2-linoleoyl-GPI (18:0/18:2) levels | GCST90200067 | 0.18 |
| 6954 | DTI TBSS MD Posterior thalamic radiation R | GCST90384600 | 0.18 |
| 6955 | Treatment/medication code - ramipril | Medications | UKBB00000856 | 0.18 |
| 6956 | Triglyceride to HDL cholesterol ratio | GCST90295953 | 0.18 |
| 6957 | Degree of unsaturation | GCST90502737 | 0.18 |
| 6958 | F-small fish liking (derived food-liking factor) | GCST90094840 | 0.18 |
| 6959 | Phospholipids to Total Lipids in Large LDL percentage | GCST90498058 | 0.18 |
| 6960 | EPHB4/ESAM ratio | GCST90314679 | 0.18 |
| 6961 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T166 | ECGU000166 | 0.18 |
| 6962 | Saturated fatty acids to total fatty acids percentage | GCST90499966 | 0.18 |
| 6963 | Ximenoylcarnitine (C26:1) levels | GCST90200149 | 0.18 |
| 6964 | CD274 levels | GCST90274832 | 0.18 |
| 6965 | SOD3 levels | GCST90470706 | 0.18 |
| 6966 | AIFM1 levels | GCST90468268 | 0.18 |
| 6967 | Omega-3 fatty acid levels | GCST90502422 | 0.18 |
| 6968 | Benign neoplasm: Sigmoid colon | FING00000203 | 0.18 |
| 6969 | STK24/TDRKH ratio | GCST90315893 | 0.18 |
| 6970 | Dissection of aorta | FING00000467 | 0.18 |
| 6971 | Cholesterol in small HDL (UKB data field 23575) | GCST90269672 | 0.18 |
| 6972 | Phospholipids in medium LDL | GCST90498831 | 0.18 |
| 6973 | ROR1/TNFRSF21 ratio | GCST90315787 | 0.18 |
| 6974 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T61 | ECGU000061 | 0.18 |
| 6975 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T451 | ECGU000451 | 0.18 |
| 6976 | DBI/TMSB10 ratio | GCST90314414 | 0.18 |
| 6977 | IDP dMRI TBSS ICVF Inferior cerebellar peduncle L | GCST90004338 | 0.18 |
| 6978 | LCN2/RETN ratio | GCST90315308 | 0.18 |
| 6979 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T216 | ECGA000216 | 0.18 |
| 6980 | Free cholesterol levels in small VLDL | GCST90092972 | 0.18 |
| 6981 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T398 | ECGU000398 | 0.18 |
| 6982 | DTI TBSS FA Anterior corona radiata R | GCST90384402 | 0.18 |
| 6983 | ITGB1BP2 levels | GCST90469642 | 0.18 |
| 6984 | Phosphatidylcholine diacyl C36:4 levels | GCST90240040 | 0.18 |
| 6985 | Presence of other functional implants | Persons with potential health hazards related to family and personal history and certain conditions influencing health status | UKBB00000709 | 0.18 |
| 6986 | Sphingomyelin_39:1_[M+H]1+ levels | GCST90060328 | 0.18 |
| 6987 | Superficial cellulitis and abscess (PheCode 681) | GCST90476165 | 0.18 |
| 6988 | AXL/CD163 ratio | GCST90313418 | 0.18 |
| 6989 | TTN levels | GCST90470984 | 0.18 |
| 6990 | Spells in hospital | Summary Administration | UKBB00000789 | 0.18 |
| 6991 | Principal component-derived dietary pattern 7 | GCST90133012 | 0.18 |
| 6992 | Abnormal results of function study of thyro (PheCode 246.7) | GCST90475654 | 0.18 |
| 6993 | CD46/SIAE ratio | GCST90313835 | 0.18 |
| 6994 | RGMB levels | GCST90470464 | 0.18 |
| 6995 | Total cholines levels (UKB data field 23436) | GCST90269533 | 0.18 |
| 6996 | CSF2RB levels | GCST90468883 | 0.18 |
| 6997 | Total bilirubin levels (UKB data field 30840) | GCST90468104 | 0.18 |
| 6998 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T401 | ECGU000401 | 0.18 |
| 6999 | LCP1 levels | GCST90469748 | 0.18 |
| 7000 | Temporomandibular joint disorders | FING00001354 | 0.18 |